PCC Rokit (PCR) Q3 2025 earnings summary

Executive summary

• Revenue for 3Q2025 was 1,372.6 million PLN, down 6% year-over-year, with EBITDA at 198.5 million PLN (down 5.3%) and net profit at 40.8 million PLN (up 5.6%).

• Sales volumes were maintained due to product and customer diversification, supporting resilience in a challenging environment.

• Net profit growth was aided by an early PLN 52.1m energy compensation, mainly benefiting the Chlorine derivatives segment.

• Investment projects continued, including capacity expansions, energy efficiency improvements, and construction of a universal plant in Brzeg Dolny.

• Major management changes included the appointment of a new Vice President in May 2025.

Financial highlights

• 2024 consolidated revenue: 1,947.4 million PLN; EBITDA: 374.0 million PLN; net profit: 143.1 million PLN.

• 3Q2025 revenue: 1,372.6 million PLN; EBITDA: 198.5 million PLN; net profit: 40.8 million PLN.

• EBITDA margin: 14.5% (up 0.1pp); net margin: 3.0% (up 0.4pp); ROA: 1.8% (up 0.2pp); ROE: 3.1% (up 0.1pp) year-over-year.

• Operating cash flow reached 208.6 million PLN (up 9.7%), while net cash decreased by 173.8 million PLN due to investment and financing outflows.

• Dividend of 5.05 PLN per share (100.3 million PLN total) was paid in May 2025.

Outlook and guidance

• Market conditions remain challenging, especially in polyols, but diversified portfolio and customer base support resilience.

• Ongoing investments in production capacity and energy efficiency are expected to enhance future competitiveness.

• Management expects continued operational cash flow to cover investments and debt service, but highlights high market volatility and macroeconomic uncertainty.

• No formal financial forecasts for 2025 were published.